Cargando…

The discrediting of the monoamine hypothesis

BACKGROUND: The monoamine hypothesis has been recognized for over half a century as a reference point to understanding electrical dysfunction associated with disease states, and/or regulatory dysfunction related to synaptic, centrally acting monoamine concentrations (serotonin, dopamine, norepinephr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinz, Marty, Stein, Alvin, Uncini, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282597/ https://www.ncbi.nlm.nih.gov/pubmed/22371656 http://dx.doi.org/10.2147/IJGM.S27824

Ejemplares similares

The Discrediting of the Monoamine Hypothesis [Retraction]
Publicado: (2020)

The Discrediting of the Monoamine Hypothesis [Expression of Concern]
Publicado: (2020)

Monoamine depletion by reuptake inhibitors
por: Hinz, Marty, et al.
Publicado: (2011)

Relative nutritional deficiencies associated with centrally acting monoamines
por: Hinz, Marty, et al.
Publicado: (2012)

The dual-gate lumen model of renal monoamine transport
por: Hinz, Marty, et al.
Publicado: (2010)

Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
por: Hinz, Marty, et al.
Publicado: (2011)

Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
por: Hinz, Marty, et al.
Publicado: (2011)

APRESS: apical regulatory super system, serotonin, and dopamine interaction
por: Hinz, Marty, et al.
Publicado: (2011)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Hinz, Marty, et al.
Publicado: (2010)

Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
por: Hinz, Marty, et al.
Publicado: (2011)

Discreditable
Publicado: (1869)

Neurotransmitter testing of the urine: a comprehensive analysis
por: Hinz, Marty, et al.
Publicado: (2010)

5-HTP efficacy and contraindications
por: Hinz, Marty, et al.
Publicado: (2012)

Amino acid-responsive Crohn’s disease: a case study
por: Stein, Alvin, et al.
Publicado: (2010)

Amino acid management of Parkinson’s disease: a case study
por: Hinz, Marty, et al.
Publicado: (2011)

The One Discredited Material
Publicado: (1894)

Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population
por: Trachte, George J, et al.
Publicado: (2009)

Social Identity Threat Motivates Science-Discrediting Online Comments
por: Nauroth, Peter, et al.
Publicado: (2015)

Changing schools in students with anorexia nervosa: escaping discredited identity
por: Bowtell, Evelyn, et al.
Publicado: (2013)

Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression
por: Marathe, Swananda V, et al.
Publicado: (2018)

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
por: Parkinson, Lynne, et al.
Publicado: (2011)

Management of L-dopa overdose in the competitive inhibition state
por: Hinz, Marty, et al.
Publicado: (2014)

Revisiting the Monoamine Hypothesis of Depression: A New Perspective
por: Goldberg, Joel S, et al.
Publicado: (2014)

The Parkinson’s disease death rate: carbidopa and vitamin B6
por: Hinz, Marty, et al.
Publicado: (2014)

Parkinson’s disease-associated melanin steal
por: Hinz, Marty, et al.
Publicado: (2014)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation
por: McEwen, Bruce S., et al.
Publicado: (2009)

Microperforation prolotherapy: a novel method for successful nonsurgical treatment of atraumatic spontaneous anterior sternoclavicular subluxation, with an illustrative case
por: Stein, Alvin, et al.
Publicado: (2011)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz, Marty, et al.
Publicado: (2016)

Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
por: Hinz, Marty, et al.
Publicado: (2014)

Discrediting experiences: outcomes of eligibility assessments for claimants with psychiatric compared with non-psychiatric conditions transferring to personal independence payments in England
por: Pybus, Katie, et al.
Publicado: (2019)

Discrediting experiences: outcomes of eligibility assessments for claimants with psychiatric compared with non-psychiatric conditions transferring to personal independence payments in England – ERRATUM
por: Pybus, Katie, et al.
Publicado: (2019)

Ad Hominem Criticisms: An Old Trick to Discredit Inconvenient Research. A Response to Oakley et al. And the International Chiropractors Association Rapid Response Research Review Subcommittee
por: Côté, Pierre, et al.
Publicado: (2021)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

3-Coumaranone derivatives as inhibitors of monoamine oxidase
por: Van Dyk, Adriaan S, et al.
Publicado: (2015)

Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers
por: Jönsson, Erik G, et al.
Publicado: (2004)

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain
por: Cai, Lu, et al.
Publicado: (2016)

Characterization of murine polyspecific monoamine transporters
por: Miura, Yamato, et al.
Publicado: (2017)

Monoamine Innervation of the Cerebral Cortex
por: Krystal, John H.
Publicado: (1985)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_lvfk842jhde4u1mj3jsa8meb3j